SCHEMBL5899544

SCHEMBL5899544

O=C(CNS(=O)(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 4/20 0.58
MMP1 P03956 2/20 0.57
MMP12 P39900 2/20 0.57
GAA P10253 1/20 0.57
MEP1B Q16820 3/20 0.53
MMP2 P08253 1/20 0.53
MMP3 P08254 1/20 0.53
MMP7 P09237 1/20 0.53
MMP9 P14780 1/20 0.53
MMP8 P22894 1/20 0.53
MMP13 P45452 1/20 0.53
MMP14 P50281 1/20 0.53
ADAM17 P78536 1/20 0.53
KDM4E B2RXH2 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
CYP3A4 P08684 1/20 0.52
MAPT P10636 1/20 0.52
HPGD P15428 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899467 0.90 KAT6A (0.72) KAT6AMMP1MMP12GAAMEP1B
SCHEMBL5899737 0.89 MMP1 (0.63) KAT6AMMP1MMP12GAAMEP1B
SCHEMBL5899482 0.89 L3MBTL1 (0.60) KAT6AMMP1MMP12GAAMEP1B
SCHEMBL23014361 0.89 KAT6A (0.58) KAT6AMMP1MMP12GAAMEP1B
SCHEMBL5320466 0.89 ALDH1A1 (0.60) KAT6AMMP1MMP12GAASMN1; SMN2
SCHEMBL9777953 0.86 MEP1B (0.61) KAT6AMMP1MMP12GAAMEP1B
SCHEMBL5899447 0.86 MMP2 (0.70) KAT6AMMP1MMP12GAAMEP1B
SCHEMBL5899468 0.85 MEN1 (0.67) KAT6AMMP1MMP12GAASMN1; SMN2
SCHEMBL5899481 0.85 ALDH1A1 (0.56) KAT6AMMP1MMP12GAAMEN1
SCHEMBL23014260 0.85 KAT6A (0.52) KAT6AMMP1MMP12GAAMEP1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110204464-B Synthesis method of aryl tertiary sulfonamide compound 西北师范大学 2021-05-04 CN disclosed
CN-110204464-A A kind of synthetic method of the tertiary sulfamide compound of aryl 西北师范大学 2019-09-06 CN disclosed
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 KAT6A 2440/4885MMP1 369/4885MMP12 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.